Systemic inflammation in progressive multiple sclerosis involves follicular T-helper, Th17- and activated B-cells and correlates with progression.
about
Can follicular helper T cells be targeted to improve vaccine efficacy?Th17 Cells Pathways in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders: Pathophysiological and Therapeutic ImplicationsThe potential role for ocrelizumab in the treatment of multiple sclerosis: current evidence and future prospectsFollicular Helper CD4+ T Cells in Human Neuroautoimmune Diseases and Their Animal ModelsStage-specific immune dysregulation in multiple sclerosisPotential of Cells and Cytokines/Chemokines to Regulate Tertiary Lymphoid Structures in Human DiseasesCirculating immune cells in multiple sclerosis.iNKT Cells in Secondary Progressive Multiple Sclerosis Patients Display Pro-inflammatory Profiles.Therapeutic interference with leukocyte recirculation in multiple sclerosis.Primary Progressive Multiple Sclerosis: Putting Together the PuzzleSystemic frequencies of T helper 1 and T helper 17 cells in patients with age-related macular degeneration: A case-control study.Regulatory T cells in multiple sclerosis and myasthenia gravis.Protease-activated receptor-1 activation by granzyme B causes neurotoxicity that is augmented by interleukin-1βTh1 and Th17 Cells and Associated Cytokines Discriminate among Clinically Isolated Syndrome and Multiple Sclerosis Phenotypes.Circulating concentrations of interleukin (IL)-17 in patients with multiple sclerosis: Evaluation of the effects of gender, treatment, disease patterns and IL-23 receptor gene polymorphismsCirculating CXCR5+PD-1+ response predicts influenza vaccine antibody responses in young adults but not elderly adults.The cytokine TGF-β co-opts signaling via STAT3-STAT4 to promote the differentiation of human TFH cellsDysregulation of the IL-23/IL-17 axis and myeloid factors in secondary progressive MS.CXCL13 antibody for the treatment of autoimmune disorders.Pathophysiology of T follicular helper cells in humans and miceCirculating CCR7+ICOS+ Memory T Follicular Helper Cells in Patients with Multiple Sclerosis.Interleukin17A Promotes Postoperative Cognitive Dysfunction by Triggering β-Amyloid Accumulation via the Transforming Growth Factor-β (TGFβ)/Smad Signaling PathwayThe Role of IL-17 and Th17 Lymphocytes in Autoimmune DiseasesLipocalin-2 is increased in progressive multiple sclerosis and inhibits remyelinationCirculating memory T follicular helper subsets, Tfh2 and Tfh17, participate in the pathogenesis of Guillain-Barré syndrome.Absence of systemic oxidative stress and increased CSF prostaglandin F2α in progressive MS.Differential influences of the aryl hydrocarbon receptor on Th17 mediated responses in vitro and in vivo.The use of immune modulating drugs for the treatment of multiple sclerosis.Increased Circulating T Follicular Helper Cells Are Inhibited by Rituximab in Neuromyelitis Optica Spectrum Disorder.The Correlation of CD206, CD209, and Disease Severity in Behçet's Disease with Arthritis.Teriflunomide and its mechanism of action in multiple sclerosis.Human T follicular helper (Tfh) cells and disease.Interleukin-21: a double-edged sword with therapeutic potential.Phenotype and functions of memory Tfh cells in human blood.Th17 cells in autoimmune diseases.Role of T Follicular Helper cells in Multiple Sclerosis.Immunomodulatory properties of the IL-6 cytokine family in multiple sclerosis.T cell specific Cxcr5 deficiency prevents rheumatoid arthritis.IL-21 and IL-21 receptor in the immunopathogenesis of multiple sclerosis.T follicular helper (Tfh) cells in lupus: Activation and involvement in SLE pathogenesis.
P2860
Q26753848-BF29C4CD-C8DF-4867-9AD4-048D4E683E23Q26768649-B1D89465-3E0A-451B-B018-684C984A9FD6Q26770815-9820B45D-9DCD-46AF-94D6-9FBBEC67B580Q26795577-02D0E320-2FB7-4FC6-9527-F859BBB8F28EQ26852859-5D6518A5-9128-4B2C-AE43-10308DFE5EB9Q28071670-BB72F6F6-C551-4201-AF6F-EA3573DE0CD0Q30242026-96C23DDB-4EB4-4CFA-BFDE-C7BF16AEABA9Q30368046-A564A726-03AB-45FB-A202-B9782545E510Q30884219-6432725D-2E52-4A20-9336-63AE64AA4B8EQ33365606-2B2F8CB2-3D3D-4380-B5A8-CB82FB9A7439Q33677692-2B32F170-7E2B-4FBA-AFE7-26863A14C43BQ33784969-622F8F35-E13F-4E8C-BCC6-E9DA1950057FQ33846630-D48DBC0A-85EA-41BE-9F4F-DE1B3116A227Q33855341-292C78BF-920A-4AE0-94EF-E72703377E1FQ33896806-9A803AC4-4ED3-4D05-ADD1-E4F442B319A5Q34218702-5DAA26E0-68F7-464F-865D-2DB9BCD1E341Q34280534-6A60D57C-CB3B-4A4B-9A4A-137307D243A1Q34465422-03955473-446F-4FEA-992F-75AD96A7629AQ35086918-4E4CAC7B-476F-4EBF-93BB-1124E3F72D01Q35695090-4108A4BC-A8C1-4B16-9081-D789B998D28AQ35731510-EAED6E1B-8B28-418D-B83D-EB4740B281C2Q35824163-1F047417-924D-4A01-89F5-CDFCD0CAEC00Q36249305-97D16540-C386-4456-8388-0649FE33AC74Q36451661-0E06E24C-ECDD-45B2-A4DF-FB40503AB6F8Q36569933-2D07D995-F342-49CF-9EAB-1DD9A4B8C3E3Q37058064-B5DABA97-C93F-4D5B-91BB-15705730B9E3Q37308932-112AC093-452B-4DD3-A6F5-85E20D6E17FCQ37577290-33D7B564-D480-443E-B18E-C5BF8D8CBD69Q37699554-B83E86E8-01BD-4E46-B3F5-B0E9ADCE41DBQ37717039-7A56CD05-0902-4611-955C-CD4277EAA2EBQ37730005-DA033D8D-15E1-4955-BF61-9B0FC777083DQ38154471-2892F747-F990-4440-B5EB-7166A9ECC21EQ38206058-BD696E3C-59A0-4E4C-9DFD-322B221452EFQ38226748-BD05F443-176B-49A0-BF29-826689D4461CQ38344543-ABB9CDA8-7C7A-4360-BA68-65CEEEA702DBQ38530157-51DCC7A5-E3E8-4EC9-9ECB-85D212796080Q38534740-61B0BCD3-CA04-452B-BB66-0926E637396EQ38615369-C96869B9-B79F-4C64-A880-1E877199CC7EQ38617794-0812664B-524C-4214-BC11-5335F31D014CQ38650724-5E7F7F3F-0D4C-4D7E-A7F3-9233F939A16D
P2860
Systemic inflammation in progressive multiple sclerosis involves follicular T-helper, Th17- and activated B-cells and correlates with progression.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Systemic inflammation in progr ...... d correlates with progression.
@ast
Systemic inflammation in progr ...... d correlates with progression.
@en
Systemic inflammation in progr ...... d correlates with progression.
@nl
type
label
Systemic inflammation in progr ...... d correlates with progression.
@ast
Systemic inflammation in progr ...... d correlates with progression.
@en
Systemic inflammation in progr ...... d correlates with progression.
@nl
prefLabel
Systemic inflammation in progr ...... d correlates with progression.
@ast
Systemic inflammation in progr ...... d correlates with progression.
@en
Systemic inflammation in progr ...... d correlates with progression.
@nl
P2093
P2860
P50
P1433
P1476
Systemic inflammation in progr ...... d correlates with progression.
@en
P2093
Fredrik Piehl
Jeppe Romme Christensen
Lars Börnsen
Rikke Ratzer
Tomas Olsson
P2860
P304
P356
10.1371/JOURNAL.PONE.0057820
P407
P577
2013-03-01T00:00:00Z